Download PDF
Thromb Haemost 2001; 86(06): 1591-1592
DOI: 10.1055/s-0037-1616774
Letters to the Editor
Schattauer GmbH

How Old Is Factor V Leiden Mutation?

A. R. Pawar
1   Institute of Immunohaematology, New Multistoreyed Building, K. E. M. Hospital Campus, Mumbai, India
,
Shrimati Shetty
1   Institute of Immunohaematology, New Multistoreyed Building, K. E. M. Hospital Campus, Mumbai, India
,
K. Ghosh
1   Institute of Immunohaematology, New Multistoreyed Building, K. E. M. Hospital Campus, Mumbai, India
,
Dipika Mohanty
1   Institute of Immunohaematology, New Multistoreyed Building, K. E. M. Hospital Campus, Mumbai, India
› Author Affiliations
Further Information

Publication History

Received 17 May 2001

Accepted after resubmission 13 July 2001

Publication Date:
12 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (Activated protein C resistance). Blood 1995; 85: 1504-8.
    PubMedGoogle Scholar
  • 2 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
    CrossrefPubMedGoogle Scholar
  • 3 Gregg JP, Yamane AJ, Grody WW. Prevalence of the factor V Leiden mutation in four distinct American ethnic populations. Am J Med Genet 1997; 73: 334-6.
    CrossrefPubMedGoogle Scholar
  • 4 Arruda VR, Annichino-Bizzacchi JM, Costa FF, Reitsma PH. Factor V Leiden (FVQ506) is common in a Brazilian population. Am J Hemat 1995; 49: 242-3.
    CrossrefPubMedGoogle Scholar
  • 5 Mohanty D, Shetty S, Narayana TS, Abraham P. Factor V Leiden mutation and Budd-Chiari syndrome. Blood 1998; 92: 1838-9.
    PubMedGoogle Scholar
  • 6 Garewal G, Das R, Chawla Y, Dhiman RK. Budd-Chiari syndrome associated with homozygous factor V Leiden mutation. Br J Hemat 1999; 105: 842.
    PubMedGoogle Scholar
  • 7 Kirl RL, Keats B, Blake NM, Mc Dermid EM, Ala F, Karimi M, Nickbim B, Shabazi H, Kmet J. Genes and people in the Caspian Littoral: A population genetic study in northern Iran. Am J Phys Anthropol 1977; 46: 377.
    CrossrefPubMedGoogle Scholar
  • 8 Rees DC. The population genetics of factor V Leiden (Arg 506→Gln). Br J Hemat 1996; 95: 579-86.
    CrossrefPubMedGoogle Scholar
  • 9 Richards M, Corte-Real H, Foster P, Macaulay V, Wilkinson-Herbots H, Demaine A, Papiha S, Hedges R, Bandelt H-J, Sykes B. Paleolithic and Neolithic lineages in the European mitochondrial gene pool. Am J Hum Genet 1996; 59: 185-203.
    PubMedGoogle Scholar
  • 10 Cox MJ, Rees DC, Martinson JJ, Clegg JB. Evidence for a single origin of FVL. Br J Hemat 1996; 92: 1022-6.
    CrossrefPubMedGoogle Scholar
  • 11 Zivelin A, Yakar S, Brenner B, Eldor A, Rosenberg N, Seligsohn U. Haplotype analysis of the factor V gene in Arabs and Jews suggests that the Arg 506→Gln mutation causing resistance to activated protein C evolved from a common ancester (Abstract). Br J Hemat 1996; 93 (Suppl. 02) 6-7.
    CrossrefPubMedGoogle Scholar